B7H3-CAR-HSC

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameB7H3-CAR-HSC
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionAnti-CD276
TargetsCD276 antigen
Therapy Area/IndicationsRhabdomyosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmugenia Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmugenia Inc
Inactive CompaniesN/A
Active IndicationsRhabdomyosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A